Select Field
Select Ministry
10 results
Technology Introduction: This technology integrates AI-PRS (Artificial Intelligence-guided Phenotypic Response Surface) with zebrafish liver cancer models to establish a visualized and quantifiable decision-making platform for integrative therapies. It rapidly identifies the optimal combinations of natural compounds and targeted drugs, achieving enhanced efficacy with minimized toxicity. The platform demonstrates strong translational potential, offering a novel tool for personalized therapy design and exhibition-ready applications. Industry Applicability: Integrating AI computation with zebrafish in vivo modeling and an East-West integrative medical perspective, the platform rapidly evaluates the efficacy and toxicity of drug combinations in physiological contexts. Compared with conventional cell-based assays, it offers superior accuracy and efficiency. Potential applications include natural product drug development, personalized dosing optimization, and AI-powered clinical decision support systems, with significant commercialization and international collaboration prospects.
Future Tech | Biotechnology ＆ Medical careTechnology Introduction: This technology is a fast-acting dual-agonist that simultaneously activates μ-opioid receptor and nociceptin receptor, exhibiting high safety. It rapidly activates μ-opioid receptor to effectively relief pain. Additionally, it can reduce drug tolerance, enhance safety, and alleviate constipation by activating nociceptin receptor. The promotion of this technology will be facilitated through the postoperative pain market. Industry Applicability: • Innovation: Novel small molecule MOR/NOP dual agonist providing rapid pain relief. • Safety Advantage: No hematological or biochemical toxicity, minimal gastrointestinal effects, and absence of tolerance development. • Market Positioning: Best-in-class small molecule MOR/NOP dual agonist analgesic. • IP Protection: Robust global patent protection for compound composition.
Future Tech | Biotechnology ＆ Medical careTechnology Introduction: Reverse genetics is an important recombinant DNA technology used to study the function of RNA viral genes. This technology can be used to create full-length, infectious cDNA clones of enteroviruses, generating pure enterovirus strains and avoiding the quasispecies resulting from errors in RNA virus replication. Alternatively, mutant strains can be generated through point mutations to study the characteristics caused by enterovirus gene mutations. Industry Applicability: This project develops a technology platform for bioeconomy to assist and support the local bio-industry in developing the emerging enterovirus vaccines, thereby promoting the development of the local pharmaceutical and biotechnology industry.
Future Tech | Biotechnology ＆ Medical careTechnology Introduction: The present disclosure relates to a fusion protein comprising a peptide binding to heparan sulfate binding activity and an IgG Fc region. The present disclosure also relates to a method for promoting macrophage and/or megakaryocyte differentiation and/or maturation. Industry Applicability: The present disclosure is a novel strategy for treating wounds and/or tissue damage, which can be applied to regenerative medicine.
Future Tech | Biotechnology ＆ Medical careTechnology Introduction: Fungal infections claim millions of lives each year. This technology focuses on the rapid and accurate detection of drug-resistant pathogenic fungi, enabling frontline clinical teams to perform timely diagnostics and enhancing the effectiveness of medicine. It is also applicable to large-scale screening, providing appropriate treatment guidance for fungal infections and thereby reducing their threat to public health. Industry Applicability: This technology offers two rapid, convenient, and accurate approaches for detecting the drug-resistant clade 4 genotype of Candida tropicalis. One method is designed for large-scale screening and can be flexibly expanded. The other is tailored for frontline settings such as hospitals, clinics, and diagnostic laboratories to enable timely and efficient detection.
Future Tech | Biotechnology ＆ Medical careTechnology Introduction: This technology uses peripheral blood biomarkers—NfL for brain injury, CCL11 for stress-induced alcohol use, Nectin-4 for opioid/ketamine addiction, and MPO for alcohol relapse. These markers provide objective, quantifiable tools to improve diagnosis and treatment in addiction medicine. The approach is innovative, clinically valuable, and holds strong market and industrial potential. Industry Applicability: This technology supports clinical diagnostics, precision medicine, and telehealth by enabling objective assessment of addiction and brain injury. Biomarkers can be integrated into platforms like SIMOA and ELLA to develop new tools. It aids personalized care and offers value in public health and clinical training.
Future Tech | Biotechnology ＆ Medical careTechnology Introduction: Within the MRI environment, strong magnetic fields and radiofrequency pulses may introduce potential safety risks for medical devices. Consequently, the evaluation of MRI compatibility for medical devices and implants have become a critical focus in recent medical device development. Our laboratory has established a comprehensive platform for MRI compatibility testing and evaluation. The testing procedures are conducted in accordance with ASTM standards, and we are able to provide test reports that comply with ISO 17025 requirements. This enables manufacturers to rigorously assess both the MRI compatibility and safety of their products. Industry Applicability: We have successfully established this testing platform, thereby strengthening the MRI compatibility of medical devices and implants. The platform markedly improves the safety of such devices in MRI environments, while simultaneously facilitating domestic academic, industrial, and research institutions in obtaining regulatory approvals from international authorities. Consequently, it enhances both the global competitiveness and the intrinsic value of these medical device products.
Future Tech | Biotechnology ＆ Medical careTechnology Introduction: The Laboratory Animal Center: Enabling Excellence in Animal Research 1.Globally Accredited: Four consecutive full accreditations from AAALAC international 2.State-of-the-Art Facilities: Specialized zones for rodent housing, infectious studies, experiments, surgeries, and centralized cleaning & sterilization 3.Expert teams: Comprehensive animal care, technical and veterinary support 4.Education and Ethics: Foundational training programs in animal experimental techniques, promoting the 3Rs principle and animal welfare 5.Advanced Service Platforms: Husbandry, health monitoring, drug administration, biosampling, behavioral phenotyping and transgenic technologies 6. Innovative Technology: RodentWatch AI system leveraging deep learning for automated behavioral and neuroscience research
Future Tech | Biotechnology ＆ Medical careTechnology Introduction: This invention describes the discovery and development of BPR5K230, a potent, orally bioavailable AXL and MERTK selective kinase inhibitor targeting tumor and tumor immune microenvironment for the treatment of triple negative breast cancer patients who fail current therapies and whose tumors and immune cells overexpress AXL and MERTK. The current invention represents a novel target-driven, patient-stratified precision cancer medicine for tough-to-treat cancers.
Future Tech | Biotechnology ＆ Medical careTechnology Introduction: The Long-Term Care Service Institution Resource Integration Platform consolidates information from long-term care institutions nationwide. The platform is designed to enhance information transparency while reducing the administrative burden on service providers. It offers personalized service options and care consultation tailored to the needs of older adults. By providing an intuitive system for resource search and navigation, the platform increases the accessibility and convenience of obtaining care resources. Furthermore, it enables the public to share their experiences with service institutions, thereby fostering continuous improvement in the quality of long-term care services. Industry Applicability: The Long-Term Care Service Institution Resource Integration Platform consolidates information from long-term care institutions nationwide. The platform is designed to enhance information transparency while reducing the administrative burden on service providers. It offers personalized service options and care consultation tailored to the needs of older adults. By providing an intuitive system for resource search and navigation, the platform increases the accessibility and convenience of obtaining care resources. Furthermore, it enables the public to share their experiences with service institutions, thereby fostering continuous improvement in the quality of long-term care services.
Future Tech | Biotechnology ＆ Medical careComing soon!
